CAS 2244904-70-7

(R)-6,7-Dimethoxy-2-Methyl-N-(1-(4-(2-((Methylamino)Methyl)Phenyl)Thiophen-2-Yl)Ethyl)Quinazolin-4-Amine

CAS: 2244904-70-7

(R)-6,7-Dimethoxy-2-Methyl-N-(1-(4-(2-((Methylamino)Methyl)Phenyl)Thiophen-2-Yl)Ethyl)Quinazolin-4-Amine

Pureza: 98%

Peso molecular: 448.58g/mol

Ref: 54-OR1023264

BAY-293

CAS: 2244904-70-7

BAY-293

Pureza: ≥95%

Peso molecular: 448.58g/mol

Ref: 54-BUP04710

BAY-293

CAS: 2244904-70-7

BAY-293 is a potent, cell-active SOS1 inhibitor that disrupts the KRAS-SOS1 interaction (IC50: 21 nM).

Fórmula: C₂₅H₂₈N₄O₂S

Pureza: 97.16%

Forma y color: Solid

Peso molecular: 448.58

Ref: TM-T5418

(R)-6,7-Dimethoxy-2-methyl-N-(1-(4-(2-((methylamino)methyl)phenyl)thiophen-2-yl)ethyl)quinazolin-4-amine

CAS: 2244904-70-7

Pureza: 98.0%

Forma y color: Liquid, No data available.

Peso molecular: 448.5899963378906

Ref: 10-F546324

6,7-Dimethoxy-2-methyl-N-[(1R)-1-[4-[2-[(methylamino)methyl]phenyl]-2-thienyl]ethyl]-4-quinazolinamine

Producto controlado

CAS: 2244904-70-7

Fórmula: C₂₅H₂₈N₄O₂S

Forma y color: Neat

Peso molecular: 448.58

Ref: TR-D224490

BAY 293

CAS: 2244904-70-7

BAY 293 is a tyrosine kinase inhibitor that blocks the epidermal growth factor receptor (EGFR) and prevents it from binding to the epidermal growth factor (EGF). The BAY 293 also inhibits the activity of other protein kinases, such as Shp2, which are involved in signal transduction pathways. It has been shown to inhibit tumor formation in mice with sarcoma viral oncogene-induced tumors. BAY 293 binds covalently to the enzyme, thereby inhibiting its function. This compound has been shown to be effective against cancer cells that have overactive EGFR and Shp2 proteins.

Fórmula: C₂₅H₂₈N₄O₂S

Pureza: Min. 95%

Peso molecular: 448.59 g/mol

Ref: 3D-UPD90470